Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone versus sufentanil for postoperative analgesia after hip replacement in elderly patients
ChiCTR2000030999Phase 4Not yet recruiting
- Sponsor
- Peking University Shougang Hospital
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydromorphone and sufentanil in postoperative pain (2 arms), sponsored by Peking University Shougang Hospital. Primary endpoint: Postoperative pain score. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
hydromorphonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000030999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030999.